Lipopolysaccharide Administration Alters Extracellular Vesicles in Cell Lines and Mice

Area of Science:

• Cell Biology
• Infection Biology
• Biomarker Discovery

Background:

• Extracellular vesicles (EVs) are crucial in cellular communication and infection processes.
• EVs show promise as biomarkers for diagnostics.
• Bacterial lipopolysaccharide (LPS) is a key component in bacterial infections.

Purpose of the Study:

• To investigate the in vitro effects of LPS on cell lines relevant to bacterial infection.
• To examine the impact of LPS on EV biogenesis and cargo composition in vivo.
• To assess the potential of LPS-induced EV changes as diagnostic indicators.

Main Methods:

• Treatment of A549 and BV-2 cell lines with varying LPS concentrations.
• Analysis of EV numbers and cargo (Interleukin-6, Lysosomal-Associated Membrane Protein 1, Tumor Necrosis Factor) from treated cell lines.
• Administration of LPS to BALB/c mice and analysis of serum-isolated EVs for LAMP1 and Toll-like Receptor 4 (TLR4) levels.

Main Results:

• LPS treatment caused significant changes in EV numbers in A549 and BV-2 cells.
• EVs from LPS-treated A549 cells showed reduced packaging of IL-6 and LAMP1.
• EVs from LPS-treated BV-2 cells exhibited decreased TNF packaging.
• Serum EVs from LPS-treated mice displayed elevated LAMP1 and TLR4 levels.

Conclusions:

• LPS significantly alters EV production and cargo composition in both in vitro and in vivo models.
• These findings highlight the influence of bacterial components on EV characteristics.
• Modulated EV profiles in response to LPS warrant further investigation for diagnostic potential.